News and commentary about white-collar crime, enforcement, and compliance
Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
GlaxoSmithKline said Monday some of its executives in China appear to have broken the law in the giant bribery scandal still unfolding there.
Abbas Hussain, the head of emerging markets for the U.K.-based… Continue Reading
As the GlaxoSmithKline bribery investigation widens, it will soon engulf hundreds of third parties across China, accused of being conduits for bribe paying.
We decided to retrieve the basic Administration of Industry and Commerce (AIC) filings for a quick due diligence on one of the travel agents named — Shanghai Linjiang International Travel Agency.… Continue Reading
China state TV has broadcast a confession by GlaxoSmithKline’s vice president of China operations.
Liang Hong, 49, admitted bribing doctors when he appeared Monday from his jail cell during the evening newscast on China Central Television (CCTV).… Continue Reading